These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 28261681)

  • 21. Zone-dependent expression of estrogen receptors alpha and beta in human benign prostatic hyperplasia.
    Tsurusaki T; Aoki D; Kanetake H; Inoue S; Muramatsu M; Hishikawa Y; Koji T
    J Clin Endocrinol Metab; 2003 Mar; 88(3):1333-40. PubMed ID: 12629127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative studies of the expression of estrogen receptor-alpha and estrogen receptor-beta in prostatic carcinoma].
    Yang GS; Chen ZD
    Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(18):1111-5. PubMed ID: 15498298
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of estrogen receptor (ER)-alpha and ER-beta in normal and malignant prostatic epithelial cells: regulation by methylation and involvement in growth regulation.
    Lau KM; LaSpina M; Long J; Ho SM
    Cancer Res; 2000 Jun; 60(12):3175-82. PubMed ID: 10866308
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estrogen and G protein-coupled estrogen receptor accelerate the progression of benign prostatic hyperplasia by inducing prostatic fibrosis.
    Yang Y; Sheng J; Hu S; Cui Y; Xiao J; Yu W; Peng J; Han W; He Q; Fan Y; Niu Y; Lin J; Tian Y; Chang C; Yeh S; Jin J
    Cell Death Dis; 2022 Jun; 13(6):533. PubMed ID: 35672281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estradiol promotes epithelial-to-mesenchymal transition in human benign prostatic epithelial cells.
    Shi X; Peng Y; Du X; Liu H; Klocker H; Lin Q; Shi J; Zhang J
    Prostate; 2017 Oct; 77(14):1424-1437. PubMed ID: 28850686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of receptor expression with prostate volume in benign prostatic hyperplasia.
    Sreenivasulu K; Nandeesha H; Dorairajn LN; Rajesh NG
    Indian J Pathol Microbiol; 2019; 62(1):99-102. PubMed ID: 30706868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epithelial-to-mesenchymal transition and estrogen receptor α mediated epithelial dedifferentiation mark the development of benign prostatic hyperplasia.
    Shao R; Shi J; Liu H; Shi X; Du X; Klocker H; Lee C; Zhu Y; Zhang J
    Prostate; 2014 Jun; 74(9):970-82. PubMed ID: 24752964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cynomorium songaricum Rupr demonstrates phytoestrogenic or phytoandrogenic like activities that attenuates benign prostatic hyperplasia via regulating steroid 5-α-reductase.
    Tao R; Miao L; Yu X; Orgah JO; Barnabas O; Chang Y; Liu E; Fan G; Gao X
    J Ethnopharmacol; 2019 May; 235():65-74. PubMed ID: 30708032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The expression and localization of estrogen receptor beta in hyperplastic and neoplastic prostate lesions.
    Levakov AF; Kaćanski MM; Vucković N; Zivojinov M; Amidzić J; Sabo JI
    Vojnosanit Pregl; 2015 Oct; 72(10):906-13. PubMed ID: 26665557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Histological localization of estrogen receptors in normal and diseased human prostates by immunocytochemistry.
    Schulze H; Claus S
    Prostate; 1990; 16(4):331-43. PubMed ID: 1695369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of acupuncture on oestrogen receptors in rats with benign prostatic hyperplasia.
    Pan L; Su S; Li Y; Liu D; Shen L; Wang H; Wen J; Hu H; Zheng R
    J Steroid Biochem Mol Biol; 2023 Nov; 234():106402. PubMed ID: 37734284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of ERalpha and ERbeta in prostate cancer.
    Linja MJ; Savinainen KJ; Tammela TL; Isola JJ; Visakorpi T
    Prostate; 2003 May; 55(3):180-6. PubMed ID: 12692783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. pS2 (TFF1) expression in prostate carcinoma: correlation with steroid receptor status.
    Abdou AG; Aiad HA; Sultan SM
    APMIS; 2008 Nov; 116(11):961-71. PubMed ID: 19132993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunolocalization of androgen receptors, estrogen alpha receptors, and estrogen beta receptors in experimentally induced canine prostatic hyperplasia.
    Gallardo F; Lloreta J; García F; Moll X; Baró T; González LA; Morote J; Reventos J; Mogas T
    J Androl; 2009; 30(3):240-7. PubMed ID: 19136389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia.
    Alonso-Magdalena P; Brössner C; Reiner A; Cheng G; Sugiyama N; Warner M; Gustafsson JA
    Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2859-63. PubMed ID: 19196965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of survivin and apoptotic biomarkers in benign prostatic hyperplasia.
    Shariat SF; Ashfaq R; Roehrborn CG; Slawin KM; Lotan Y
    J Urol; 2005 Nov; 174(5):2046-50. PubMed ID: 16217391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreased mitophagy aggravates benign prostatic hyperplasia in aged mice through DRP1 and estrogen receptor α.
    Hong GL; Kim KH; Kim YJ; Lee HJ; Kim HT; Jung JY
    Life Sci; 2022 Nov; 309():120980. PubMed ID: 36152678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human T47D-ERβ breast cancer cells with tetracycline-dependent ERβ expression reflect ERα/ERβ ratios in rat and human breast tissue.
    Evers NM; van de Klundert TM; van Aesch YM; Wang S; de Roos WK; Romano A; de Haan LH; Murk AJ; Ederveen AG; Rietjens IM; Groten JP
    Toxicol In Vitro; 2013 Sep; 27(6):1753-61. PubMed ID: 23680332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between changes in prostate-specific antigen and the percent of prostatic epithelium in men with benign prostatic hyperplasia.
    Cadeddu JA; Pearson JD; Lee BR; Landis P; Partin AW; Epstein JI; Carter HB
    Urology; 1995 May; 45(5):795-800. PubMed ID: 7538241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.